ArticleVaccines2023

Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine.

Zeyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.